Rebound-associated vertebral fractures after denosumab discontinuation in a lung cancer patient with bone metastases - ScienceDirect
Rebound-associated vertebral fractures may occur in sequential time points following denosumab discontinuation: need for prompt treatment re-initiation - ScienceDirect
Romosozumab was not effective in preventing multiple spontaneous clinical vertebral fractures after denosumab discontinuation: A case report - ScienceDirect
DENOSUMAB
Frontiers | Elevated Bone Hardness Under Denosumab Treatment, With Persisting Lower Osteocyte Viability During Discontinuation
Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS - ScienceDirect
Long-term follow up after denosumab treatment for osteoporosis – rebound associated with hypercalcemia, parathyroid hyperplasia, severe bone mineral density loss, and multiple fractures: a case report | Journal of Medical Case Reports
Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placeboâ•'Controlled FREEDOM
Prolia/Denosumab - Multiple vertebral fractures after stopping the drug | Facebook
Rebound Vertebral Fractures in a Patient With Lung Cancer After Oncology-Dose Denosumab Discontinuation: A Cautionary Tale - ScienceDirect
Can You Safely Discontinue Prolia and Avoid Fracture? - YouTube
Management of patients at very high risk of osteoporotic fractures through sequential treatments | Aging Clinical and Experimental Research
Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS. | Semantic Scholar
Discontinuing Denosumab: Can It Be Done Safely? A Review of the Literature
Discontinuing denosumab discouraged | Nature Reviews Rheumatology
Alert! FDA Drops Bombshell on PROLIA for Osteoporosis
Multiple Rebound-Associated Vertebral Fractures after Denosumab Discontinuation: Is Prompt Antiresorptive Therapy Always Recommended, Even When the Risk of Fracture Seems Low? A Case Report | Bentham Science
Lateral spine X-rays depicted vertebral fractures at L1 and L2 in a... | Download Scientific Diagram
Denosumab in the Treatment of Osteoporosis: 10 Years Later: A Narrative Review | Advances in Therapy
Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS. | Semantic Scholar
JCM | Free Full-Text | Similarities and Differences in the Management of Patients with Osteoporotic Vertebral Fractures and Those with Rebound-Associated Vertebral Fractures Following Discontinuation of Denosumab
Rebound hypercalcemia following denosumab discontinuation. Serum... | Download Scientific Diagram
Observations following discontinuation of long-term denosumab therapy
